ASX/PNV (ASX/PNV)

Australian Securities Exchange: ASX/PNV · AUD

A$0.88

+0.01 (+1.7%)· Recorded snapshot

Market cap	607.9M
Revenue (ttm)	149.8M
Net income (ttm)	7.3M
EPS (ttm)	A$0.01
Shares out	690.8M
P/E (trailing)	83.8x
P/E (forward)	56.4x
Volume	1,144,697
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 149.8M
Net income (ttm): 7.3M
EPS (ttm): A$0.01
P/E (trailing): 83.8x
P/E (forward): 56.4x
Market cap: 607.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E56.4

P25 n/aP50 n/aP75 n/a

Trailing P/E83.8

P25 n/aP50 n/aP75 n/a

ROE8.4

P25 n/aP50 n/aP75 n/a

ROIC17.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/PNV indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

AUD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-19
Employees	301
Employees change	47
Employees growth	18.5%
Enterprise value	AUD 590.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1998
Industry	Medical Devices
Is primary listing	Yes
ISIN number	AU000000PNV0
Last earnings date	2026-08-26
Last refreshed	2026-10-29
Market cap	AUD 607.9M
Next earnings date	2026-11-19
Price	AUD 0.88
Price currency	AUD
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-29
Symbol	asx/PNV
Website	https://polynovo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	83.81x
Average P/E ratio (3Y)	228.93x
Earnings yield	1.19%
EV/Earnings	78.97x
EV/EBIT	43.52x
EV/EBITDA	34.55x
EV/FCF	62.25x
EV/Sales	3.87x
FCF / EV yield	1.61%
FCF yield	1.56%
Forward P/E	56.35x
Graham number	0.17611
Graham upside	-80.1%
P/(FCF - SBC) ratio	61.16x
P/(OCF - SBC) ratio	25.36x
P/B ratio	6.59x
P/E ratio	83.81x
P/FCF ratio	64.17x
P/OCF ratio	25.86x
P/S ratio	3.99x
PEG ratio	1.01x
Price / tangible book value	6.62x
Price/EBITDA ratio	38.65x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	8.89%
EBITDA margin	10.32%
Effective tax rate	6.1%
FCF margin	6.21%
Gross margin	86.28%
Operating margin	8.89%
Pretax margin	5.22%
Profit margin	4.9%
Profit per employee	AUD 24,389
Profitable quarters	6
Profitable years	3
Revenue per employee	AUD 497,837
ROA	6.42%
ROA (5Y)	1.42%
ROCE	12.4%
ROE	8.44%
ROE (5Y)	3.06%
ROIC	17.17%
ROIC (5Y)	3.87%
SBC / revenue	-0.31%
Tax / revenue	0.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-44.44%
EPS growth (Q)	-25.67%
EPS growth (QoQ)	262,300%
EPS growth years	0
FCF growth (Q)	60.38%
Gross profit growth	12.38%
Gross profit growth (Q)	11.88%
Gross profit growth 3Y	33.94%
Gross profit growth 5Y	39.89%
Net income growth	-44.45%
Net income growth (Q)	-25.7%
Net income growth (QoQ)	244,500%
Net income growth years	0
OCF growth	634.09%
OCF growth (Q)	-10.33%
OCF growth (QoQ)	55.72%
Operating income growth	68.32%
Operating income growth (Q)	412.99%
Revenue growth	16.43%
Revenue growth (Q)	14.98%
Revenue growth (QoQ)	13.07%
Revenue growth 10Y	46.56%
Revenue growth 3Y	31.66%
Revenue growth 5Y	38.56%
Revenue growth quarters	18
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -13.8M
Depreciation and amortization	AUD 2.1M
EBIT	AUD 13.3M
EBITDA	AUD 15.5M
EPS	AUD 0.01
FCF per share	AUD 0.01
Financing cash flow	AUD -5.3M
Free cash flow	AUD 9.3M
Free cash flow minus SBC	AUD 9.8M
Gross profit	AUD 129.3M
Income taxes	AUD 477,000
Investing cash flow	AUD -13.7M
Net borrowing	AUD -5.3M
Net cash flow	AUD 1.9M
Net income	AUD 7.3M
Operating cash flow minus SBC	AUD 23.6M
Operating income	AUD 13.3M
Revenue	AUD 149.8M
Stock-based compensation	AUD -458,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	12.43
Book value per share	AUD 0.13
Debt / EBITDA	1.05
Debt / equity	0.19
Debt / FCF	1.89
Interest coverage	14.46
Long-term assets	AUD 58.3M
Long-term liabilities	AUD 16.8M
Net cash (debt)	AUD 17.9M
Net cash / market cap	2.99%
Net cash growth	8.58%
Net debt / EBITDA	-1.16
Net debt / equity	-0.2
Net debt / FCF	-1.92
Piotroski F-Score	7
Property, plant and equipment	AUD 44.1M
Shareholders' equity	AUD 90.7M
Tangible book value	AUD 90.3M
Tangible book value per share	AUD 0.13
Total assets	AUD 132.1M
Total cash	AUD 35.5M
Total debt	AUD 17.6M
Total liabilities	AUD 41.4M
WACC	11.46%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.15
Current assets	AUD 73.9M
Current liabilities	AUD 24.7M
Current ratio	2.99
Inventory turnover	1.69
Net working capital	AUD 16.8M
Quick ratio	2.59
Working capital	AUD 49.2M
Working capital turnover	3.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.02%
Shareholder yield	0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	188.53%
10Y return CAGR	11.18%
10Y total return	188.53%
150-day SMA	AUD 0.99
15Y price change	1,471.43%
15Y return CAGR	20.16%
15Y total return	1,471.43%
1D price change	1.73%
1M price change	-5.38%
1M total return	-5.38%
1W price change	-1.68%
1W total return	-1.68%
1Y price change	-37.14%
1Y return CAGR	-37.16%
1Y total return	-37.14%
20-day SMA	AUD 0.90
200-day SMA	AUD 0.98
20Y price change	25.71%
20Y return CAGR	1.15%
20Y total return	25.71%
3M price change	3.53%
3M total return	3.53%
3Y price change	-22.81%
3Y return CAGR	-8.27%
3Y total return	-22.81%
50-day SMA	AUD 0.96
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 1.42
52-week high date	2025-10-29
52-week low	AUD 0.81
52-week low date	2026-07-28
5Y price change	-53.32%
5Y return CAGR	-14.13%
5Y total return	-53.32%
6M price change	-10.66%
6M total return	-10.66%
All-time high	AUD 4.08
All-time high date	2020-12-21
All-time low	AUD 0.02
All-time low date	2008-11-21
Average true range (ATR)	AUD 0.03
Average volume	1.2M
Beta (1Y)	0.73
Beta (2Y)	0.88
Beta (5Y)	1.35
Change from 52-week high	-38.03%
Change from 52-week low	8.64%
Change from all-time high	-78.43%
Change from all-time low	4,531.58%
Change from open	2.92%
Day's gap	-1.16%
Dollar volume	AUD 1M
High price	AUD 0.90
Low price	AUD 0.86
Monthly RSI	39.36
Open price	AUD 0.86
Position in 52-week range	55.56%
Previous close	AUD 0.87
Price vs 150-day SMA	-10.74%
Price vs 20-day SMA	-2.44%
Price vs 200-day SMA	-10.23%
Price vs 50-day SMA	-7.92%
Relative volume	0.93
RSI	42.75
Sharpe ratio	-0.62
Sharpe ratio (3Y)	-0.02
Sharpe ratio (5Y)	-0.02
Sortino ratio	-0.78
Sortino ratio (3Y)	0.08
Sortino ratio (5Y)	0.07
Volume	1.1M
Weekly RSI	41.61
YTD price change	-28.46%
YTD total return	-28.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	601.4M
Shares change (QoQ)	-0.01%
Shares change (YoY)	-0.02%
Shares held by insiders	10.05%
Shares held by institutions	36.07%
Shares outstanding	690.8M

Deeper analysis on ASX/PNV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/PNV report

Is a complete ASX/PNV research report available?

No complete published report is available for asx/PNV (ASX/PNV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/PNV (ASX/PNV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/PNV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/PNV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/PNV

Frequently asked questions